Lykan opens manufacturing facility for cell therapies

By The Science Advisory Board staff writers

September 17, 2020 -- Lykan Bioscience has opened a new 64,000-sq-ft "smart" manufacturing facility in Hopkinton, MA.

The facility will supply advanced therapy medicines for oncology, immunology, and hematology applications, the company said.

Smart manufacturing is a computer-integrated manufacturing model that uses digital information technology and includes technical workforce training.

Takeda opens new cell therapy manufacturing facility
Takeda Pharmaceuticals said it has opened a new 24,000-sq-ft research and development (R&D) cell therapy manufacturing facility at its R&D headquarters...
MilliporeSigma expands antibody-drug conjugate manufacturing
MilliporeSigma is expanding its high-potent active pharmaceutical ingredient and antibody-drug conjugate manufacturing capabilities with a $65 million...
Thermo Fisher opens new bioprocessing collaboration center
Thermo Fisher Scientific has opened a new bioprocessing collaboration center in St. Louis to accelerate innovations in biologics manufacturing.
Irisys to manufacture Qualigen COVID-19 drug
Qualigen Therapeutics has signed a contract with Irisys for the production of AS1411, Qualigen's lead candidate for the treatment of viral diseases including...
Thermo Fisher opens manufacturing site for COVID-19 viral transport media
Thermo Fisher Scientific has opened its new $40 million facility in Lenexa, KS, dedicated to viral transport media production. The groundbreaking...

Copyright © 2020 scienceboard.net


Conferences
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter